BIOMAT Database Logo BIOMAT Database Logo

Time course of antigenaemia and seroconversion in infants with vertically acquired HIV-1 infection. 1993

A de Rossi, and L Ometto, and F Mammano, and C Zanotto, and A del Mistro, and C Giaquinto, and L Chieco-Bianchi

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015488 HIV Antigens Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (LAV) antigens. AIDS Antigens,HIV-Associated Antigens,HTLV-III Antigens,HTLV-III-LAV Antigens,LAV Antigens,Lymphadenopathy-Associated Antigens,T-Lymphotropic Virus Type III Antigens, Human,HIV Associated Antigens,HTLV III Antigens,HTLV III LAV Antigens,Lymphadenopathy Associated Antigens,T Lymphotropic Virus Type III Antigens, Human,Antigens, AIDS,Antigens, HIV,Antigens, HIV Associated,Antigens, HIV-Associated,Antigens, HTLV III,Antigens, HTLV-III,Antigens, HTLV-III-LAV,Antigens, LAV,Antigens, Lymphadenopathy Associated,Antigens, Lymphadenopathy-Associated,Associated Antigens, HIV,Associated Antigens, Lymphadenopathy,III Antigens, HTLV
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

A de Rossi, and L Ometto, and F Mammano, and C Zanotto, and A del Mistro, and C Giaquinto, and L Chieco-Bianchi
Early diagnosis of vertically acquired HIV-1 infection.
January 1991, AIDS (London, England),
A de Rossi, and L Ometto, and F Mammano, and C Zanotto, and A del Mistro, and C Giaquinto, and L Chieco-Bianchi
[Pneumocystis carinii pneumonia in infants with vertically acquired HIV infection in Switzerland].
June 1995, Schweizerische medizinische Wochenschrift,
A de Rossi, and L Ometto, and F Mammano, and C Zanotto, and A del Mistro, and C Giaquinto, and L Chieco-Bianchi
Simplification to monotherapy with lopinavir/ritonavir in adolescents with vertically acquired HIV-1 infection.
February 2012, Journal of chemotherapy (Florence, Italy),
A de Rossi, and L Ometto, and F Mammano, and C Zanotto, and A del Mistro, and C Giaquinto, and L Chieco-Bianchi
Unsuspected Pneumocystis carinii pneumonia and vertically acquired HIV infection in infants requiring intensive care.
February 1994, BMJ (Clinical research ed.),
A de Rossi, and L Ometto, and F Mammano, and C Zanotto, and A del Mistro, and C Giaquinto, and L Chieco-Bianchi
Donor HIV-1 p24 antigenaemia and course of infection in recipients Transfusion Safety Study Group.
June 1990, Lancet (London, England),
A de Rossi, and L Ometto, and F Mammano, and C Zanotto, and A del Mistro, and C Giaquinto, and L Chieco-Bianchi
Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection.
January 1996, The Journal of clinical investigation,
A de Rossi, and L Ometto, and F Mammano, and C Zanotto, and A del Mistro, and C Giaquinto, and L Chieco-Bianchi
Older children and adolescents surviving with vertically acquired HIV infection.
April 2002, Journal of acquired immune deficiency syndromes (1999),
A de Rossi, and L Ometto, and F Mammano, and C Zanotto, and A del Mistro, and C Giaquinto, and L Chieco-Bianchi
Severe airflow obstruction in vertically acquired HIV infection.
December 2014, Respirology case reports,
A de Rossi, and L Ometto, and F Mammano, and C Zanotto, and A del Mistro, and C Giaquinto, and L Chieco-Bianchi
Cholangiocarcinoma presenting in an adolescent with vertically acquired HIV infection.
October 2008, International journal of STD & AIDS,
A de Rossi, and L Ometto, and F Mammano, and C Zanotto, and A del Mistro, and C Giaquinto, and L Chieco-Bianchi
Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection.
February 2001, AIDS (London, England),
Copied contents to your clipboard!